The p400 complex takes part in this pathway and was proposed to be responsible for H2A.Z deposition into the p21 promoter. Depleting p400 by siRNA increases p21 expression in a p53 dependent manner and induces premature senescence. The mechanism of this activation is unclear. In the ERa-negative breast cancer cell line MDA-MB231 p53 is mutated and non-functional. Here we show that activation of p21 in response to HDACi treatment of these ERa-negative cells requires H2A.Z acetylation and exchange at its transcription start site. Zinc finger nucleases are artificial restriction enzymes that are comprised of custom-designed zinc finger proteins and a nuclease 1-Pyrrolidinebutanoic acid,β-[3-(3,5-dimethyl-1H-pyrazol-1-yl)phenyl]-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]-,(βS,3R)- (hydrochloride) domain derived from the FokI endonuclease. Zinc finger proteins can be designed to bind to specific sequences of DNA, allowing ZFNs to induce double- or single-strand breaks in specific regions of a genome. Such ZFN-induced breaks can induce mutations in genes of interest through errorprone non-homologous end joining or lead to the modification of genes by homologous recombination in the presence of donor DNA or single-stranded oligonucleotides. Such targeted-genome editing approaches have been carried out across a variety of species, including fruit flies, nematodes, fish, rats, plants, and human cells. Genetic modifications derived from ZFN technology greatly facilitate the investigation of biological processes. In addition, ZFN technology is actively being studied as a means of advanced gene therapy to correct pathogenic genes. One of the biggest roadblocks to the application of ZFNs is the relatively low efficiency of gene editing by ZFNs. Thus, several approaches have been undertaken to improve ZFN function. For example, the ZFN nuclease domain has been modified to improve ZFN activity and specificity. Additionally, modifying the culture temperature caused a significant increase in ZFN activity. Furthermore, our group recently reported a simple method to enrich cells that contain ZFN-induced gene disruptions. Given that these simple methods to improve the ZFN CNX-419 function have facilitated the use of ZFNs, the identification of small molecules that increase ZFN function should likewise efficiently facilitate the application of ZFNs. However, such small molecules have yet to be identified. It has
